<DOC>
	<DOC>NCT02044926</DOC>
	<brief_summary>Purpose: To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012. Hypothesis: According to 2012 consensus guidelines, enhanced solid component and main pancreatic duct size of larger than 10 mm will be significant.</brief_summary>
	<brief_title>Intraductal Papillary Mucinous Neoplasm With Malignant Change</brief_title>
	<detailed_description>1. Purpose - To investigate diagnostic performance of CT and MR in intraductal papillary mucinous neoplasm with malignant change according to international consensus guidelines 2012 2. Enroll criteria - Patient who is suspected to have pancreas IPMN on imaging - Interval between imaging study and surgery is less than 2 months - Who is scheduled for surgery due to IPMN</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients who is suspected to have IPMN by imaging study or clinician Time interval between imaging study and surgery less than 2 months Patients who have pathology results not by surgery Who is less than 20 years old Who cannot voluntarily agree study design</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>